Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

INTRODUCTION: Prostate cancer is a leading cause of cancer death among men in the Western world. Early detection of prostate cancer has been shown to decrease mortality, but has limitations with low specificity leading to unnecessary biopsies and overdiagnosis of low-risk cancers. The STHLM3 trial h...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Open
Päätekijät: Nordström, Tobias, Jäderling, Fredrik, Carlsson, Stefan, Aly, Markus, Grönberg, Henrik, Eklund, Martin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2019
Aiheet:
Urology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6576112/
https://ncbi.nlm.nih.gov/pubmed/31201191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-027816
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia